UVA photoprotection in vivo or in vitro evaluation?;Efficacite photoprotectrice dans l'UVA: Evaluation in vivo ou in vitro?

Nouvelles Dermatologiques

Volumn 17, Issue 5, 1998, Pages 321-323

  Forestier, S ^a   Moyal, D ^a  

^a L ORÉAL RECHERCHE   (France)

Author keywords

Critical wavelength; In vitro; In vivo; Persistent Pigment Darkening; Photoprotection; UVA

Indexed keywords

SUNSCREEN;

ARTICLE; ERYTHEMA; HUMAN; PIGMENT DISORDER; SKIN DEFECT; SKIN PROTECTION; SPECTRAL SENSITIVITY; SUN EXPOSURE; ULTRAVIOLET A RADIATION;

EID: 0031904691     PISSN: 07525370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Lowe NJ., Shaath NA., Pathak M.A. Sunscreens: development, evaluation and regulatory aspects. Marcel Dekker Inc., New York 1997.
2. Diffey BL. A method for broad spectrum classification of sunscreens. Int. J. Cosm. Sci. 1994; 16, 47-52.
3. Irwin C. The Current Status of UVA Testing and Labelling in the USA, in Broadspectrum Sun Protection: the Issues and Status, Intern. Conf., 11-12 March 1997, The Commonwealth Institute, London.
4. COLIPA Sun Protection Factor Test Method published by the European Cosmetic, Toiletry, and Perfumery Association (COLIPA), Brussels, Belgium, October 1994.
5. Chardon A., Moyal D., Hourseau C. Persistent pigment-darkening response as a method for evaluation of ultraviolet A protection assays, in «Sunscreens: development, evaluation and regulatory aspects». Marcel Dekker Inc., New York 1997; 559-582.
6. Diffey BL., Robson J. A new substrate to measure sunscreen protection factors throughout the ultraviolet spectrum. J. Soc. Cosmet. Chem. 1989; 40, 127-133.
7. Commission Internationale de l'Eclairage. A reference action spectrum for ultraviolet induced erythema on human skin, CIE Journal 1987; 6: 17-22.
8. L'Oréal, données internes non publiées.